Sacroiliac joint pain affects up to 30% of chronic low back pain patients, yet most regenerative therapy conversations start in the wrong place. The critical decision isn't which biologic to use—it's where the injection is placed. Learn how intra-articular vs. peri-articular protocols determine whether PRP, BMAC, or prolotherapy ever reaches your actual pain source.

Most regenerative medicine clinics offer only one treatment—PRP, stem cells, or exosomes—but tissue repair is a multi-stage biological cascade that no single modality can fully address. The biological cascade framework reveals how multi modal regenerative medicine maps each treatment to a specific healing phase for superior outcomes. Understanding this framework empowers patients to seek comprehensive care rather than settling for incomplete results.

Up to 78% of ankle arthritis cases are post-traumatic, yet most treatment guides ignore this critical distinction. This comprehensive 5-tier decision framework covers the full spectrum of ankle arthritis treatment options—from conservative management to joint-preserving surgery—tailored specifically for younger, post-traumatic patients navigating this complex condition in 2026.

Not all stem cell protocols are created equal—and 'personalized medicine' means nothing without a clinical framework to back it up. This article breaks down the 8 specific biological and clinical factors every provider must assess before designing your stem cell protocol. Learn what true stem cell treatment personalization looks like in 2026.

Most patients receive a generic medication list before stem cell therapy—without understanding why certain drugs sabotage regenerative outcomes. This guide breaks down stem cell therapy medication interactions into a 6-category biochemical framework, covering both orthopedic MSC injections and hematopoietic transplants. Learn exactly which drug classes to avoid and why, so your investment in regenerative medicine delivers maximum results.

New clinical guidelines have fundamentally changed shoulder bursitis injection treatment, limiting corticosteroids to a single administration. This shift forces a critical decision: accept the risks of repeat injections or transition to regenerative options like PRP. Here's what patients and providers need to know.